EMA Conducts Fewer GMP, More GCP and Pharmacovigilance Inspections

International Pharmaceutical Regulatory Monitor
A A
The EMA noted a steep decrease in GMP inspections in its annual report for 2017, as well as a hike in inspections for good clinical practices and nearly double the amount of pharmacovigilance inspections than the previous year.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor